Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caspase-9 Peptide | Login | Caspase-9 Peptide | ||||||||||||||||
|
||||||||||||||||||
| Caspase-9 Peptide | Login | Caspase-9 Peptide | ||||||||||||||||
|
||||||||||||||||||
| CX3CR1 Peptide | Login | CX3CR1 Peptide | ||||||||||||||||
|
||||||||||||||||||
| SARS-CoV-2 (COVID-19) Variant (B.1.429, Ca .20C) Spike RBD (L452R) Recombinant Protein | Login | SARS-CoV-2 (COVID-19) Variant (B.1.429, Ca .20C) Spike RBD (L452R) Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| SARS-CoV-2 (COVID-19) Variant (B.1.160, 20A.EU2) Spike RBD (S477N) Recombinant Protein | Login | SARS-CoV-2 (COVID-19) Variant (B.1.160, 20A.EU2) Spike RBD (S477N) Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| WNT1 Antibody | Login | WNT1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| SOX9 Antibody | Login | SOX9 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Hsc70 Antibody | Login | Hsc70 Antibody | ||||||||||||||||
|
||||||||||||||||||
| SIAH1 Antibody | Login | SIAH1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| ILF3 Antibody | Login | ILF3 Antibody | ||||||||||||||||
|
||||||||||||||||||
| TTK Antibody | Login | TTK Antibody | ||||||||||||||||
|
||||||||||||||||||
| ADAMTS4 Antibody | Login | ADAMTS4 Antibody | ||||||||||||||||
|
||||||||||||||||||
| TNK2 Antibody | Login | TNK2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| PCBP2 Antibody | Login | PCBP2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| PRG2 Antibody | Login | PRG2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| TNXB Antibody | Login | TNXB Antibody | ||||||||||||||||
|
||||||||||||||||||
| NF-kB p65 Antibody | Login | NF-kB p65 Antibody | ||||||||||||||||
|
||||||||||||||||||
| PLK1 Antibody | Login | PLK1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| MT1-MMP Antibody | Login | MT1-MMP Antibody | ||||||||||||||||
|
||||||||||||||||||
| VEGFC Antibody | Login | VEGFC Antibody | ||||||||||||||||
|
||||||||||||||||||
| GZMB Antibody | Login | GZMB Antibody | ||||||||||||||||
|
||||||||||||||||||
| MRE11A Antibody | Login | MRE11A Antibody | ||||||||||||||||
|
||||||||||||||||||
| TGFBI Antibody | Login | TGFBI Antibody | ||||||||||||||||
|
||||||||||||||||||
| DKK1 Antibody | Login | DKK1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| MAP2 Antibody | Login | MAP2 Antibody | ||||||||||||||||
|
||||||||||||||||||


